Here are four highlights:
1. Advanced Orthopaedics is one of 10 sites nationwide participating in the VENUS clinical trial, which is enrolling patients with persistent knee pain caused by injured or deteriorating meniscus cartilage to assess the safety and effectiveness of the investigational NUsurface Meniscus Implant compared to non-surgical standard care.
2. NUsurface is inserted into the knee joint through a small incision and patients typically can go home soon after the operation. After surgery, patients undergo a six-week rehabilitation program.
3. NUsurface has been used in Europe since 2008 and in Israel since 2011.
4. The VENUS study aims to enroll approximately 130 patients at orthopedic centers in the United States, Europe and Israel.
More articles on devices and implants:
NuVasive acquires distributor Mega Surgical: 4 key notes
Zimmer Biomet shares could hit $150: 4 things to know
Midwest Orthopaedic Institute offers new technology for back pain treatment: 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
